• 

  Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines. 

  BARR, MARTIN; O'BYRNE, KEN (2018)
• 

  Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial 

  O'BYRNE, KEN (2017)
• 

  Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells. 

  BARR, MARTIN; O'BYRNE, KEN (2017)
• 

  hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases 

  O'BYRNE, KEN (2017)
• 

  Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial 

  O'BYRNE, KEN (2017)

View more